Guwahati: India’s national drug price regulator has revised the maximum retail prices of 543 cancer drug brands, with some medicines becoming cheaper by more than 90%. The National Pharmaceutical Pricing Authority (NPPA) released the revised price list on Wednesday, covering several generic and biosimilar medicines. However, prices of some expensive branded cancer treatments, including Keytruda.